Mechanism Behind Pancreatic Cancer's Resistance to Chemotherapy Identified

by Sheela Philomena on  November 23, 2016 at 3:26 PM Cancer News
RSS Email Print This Page Comment
Font : A-A+

A new mechanism that causes resistance of pancreatic cancer cells to chemotherapy has been discovered by University of Liverpool research team.
Mechanism Behind Pancreatic Cancer's Resistance to Chemotherapy Identified
Mechanism Behind Pancreatic Cancer's Resistance to Chemotherapy Identified

Pancreatic cancer is one of the leading causes of cancer death and current therapies are not very effective. Thus, a better understanding of the molecular mechanisms that impair the response of cancer patients to chemotherapy, the standard treatment of care for this disease, is essential to design more effective treatments for this lethal disease.

Tumour associated macrophages (TAM) and fibroblasts are non-cancerous cells that are found within solid tumours, including pancreatic cancer. Accumulating evidence suggests that TAM and fibroblasts can support cancer progression, resistance to therapy and metastasis. However, the precise mechanisms by which these cells contribute to pancreatic cancer progression and response to therapy is not completely understood.

Chemo resistance

The research team led by Dr Ainhoa Mielgo Iza, a Sir Henry Dale Fellow, from the University's Institute of Translational Medicine, has been studying how these cells contribute to chemo resistance in pancreatic cancer.

The study has been published in Cancer Research.

These proteins activate a survival signalling pathway on pancreatic cancer cells making them resistant to chemotherapy.

Analysis of biopsies from pancreatic cancer patients revealed that this survival pathway is activated in 72% of the patients.

More effective treatment

Dr Mielgo, said: "These findings are very exciting because they uncover a mechanism that causes pancreatic cancer resistance to chemotherapy.

"Our research interest is to understand the complex interactions in the tumour microenvironment with the aim of finding new therapeutic targets for cancer.

"These results describe a combination treatment that could be more effective in treating this disease."

Source: Eurekalert

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Pancreatic Cancer Chronic Lymphocytic Leukemia Hodgkins Lymphoma Non-Hodgkins Lymphoma Chemotherapy Chemotherapy Drugs Pancreatitis Peritoneal Cancer Rhabdomyosarcoma Male Breast Cancer 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive